Media Room

A new medical condition has surfaced out of the pandemic which is becoming more prevalent in some COVID-19 survivors.

Before the COVID-19 pandemic, alcohol-related liver disease was rampant across the country with roughly 15 million people diagnosed, and the number of alcohol-related liver disease hospitalizations doubling over the last decade.

The immunomodulatory properties of hu-MSCs may prove valuable in the treatment of severe COVID-19 cases

Liver disease has steadily grown over the past 30 years to levels which qualify it as a pandemic. There is no single root cause for developing liver disease, however there are specific triggers which drive the disease forward to unprecedented levels.

Liver disease is rapidly soaring to all-time highs around the globe. This disease is not only for the aging population to be concerned about, as it is becoming a strong concern in children and young adults (up to age 40)